Walgreens Boots Alliance, Inc. - Common Stock (WBA)
11.38
+0.07 (0.62%)
NASDAQ · Last Trade: Jun 26th, 5:13 PM EDT
Detailed Quote
Previous Close | 11.31 |
---|---|
Open | 11.41 |
Bid | 11.36 |
Ask | 11.38 |
Day's Range | 11.35 - 11.44 |
52 Week Range | 8.080 - 16.00 |
Volume | 8,705,379 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | 1.000 (8.79%) |
1 Month Average Volume | 9,922,615 |
Chart
About Walgreens Boots Alliance, Inc. - Common Stock (WBA)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets. The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products. Read More
News & Press Releases
Wall Street entered full rally mode on Thursday, with the Nasdaq 100 extending its record-setting climb and the S&P 500 approaching its February peak, as easing geopolitical fears and renewed hopes for a dovish Federal Reserve lifted investor sentiment.
Via Benzinga · June 26, 2025
Walgreens Boots Alliance recorded a third-quarter adjusted earnings per share of $0.38, surpassing expectations.
Via Talk Markets · June 26, 2025
Walgreens reported Q3 revenue of $38.99 billion and adjusted EPS of 38 cents, topping estimates as healthcare gains helped offset weaker retail sales.
Via Benzinga · June 26, 2025
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.38 per share was 11.3% above analysts’ consensus estimates.
Via StockStory · June 26, 2025
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2025, which ended May 31, 2025.
By Walgreens Boots Alliance · Via Business Wire · June 26, 2025
U.S. futures rose on Thursday after a mixed close on Wednesday. Futures of major benchmark indices were trading higher.
Via Benzinga · June 26, 2025
Via Benzinga · June 26, 2025
Via Benzinga · June 26, 2025
Via Benzinga · June 26, 2025
Micron Technology’s artificial intelligence-powered third-quarter outperformance could be a welcome relief to traders who are left to contend with macro and geopolitical challenges.
Via Stocktwits · June 26, 2025
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be announcing earnings results this Thursday before market open. Here’s what to look for.
Via StockStory · June 24, 2025
Realty Income is one of the highest-quality income stocks you can buy.
Via The Motley Fool · June 24, 2025
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · June 23, 2025
During periods of market volatility, durable companies provide investors with a compelling combination of stability and dividend growth.
Via MarketBeat · June 22, 2025
The U.S. markets will be closed on Thursday, June 19, in observance of Juneteenth National Independence Day, a federal holiday commemorating the end of slavery in the United States.
Via Benzinga · June 19, 2025
Via Benzinga · June 17, 2025
Via The Motley Fool · June 16, 2025
The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant net leased Walgreens property located at 3045 Broadway Boulevard in Garland, TX for $4,273,000.
Via AB Newswire · June 16, 2025
Via The Motley Fool · June 13, 2025
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · June 13, 2025
Walgreens and Greater Than HIV/STDs, a public information campaign from KFF, are joining with health departments and community organizations to provide free rapid HIV, syphilis and hepatitis C testing at more than 575 Walgreens stores on June 27 for the nation’s largest National HIV Testing Day (NHTD) event.
By Walgreens · Via Business Wire · June 12, 2025
Beverage company Zevia (NYSE:ZVIA) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 2% year on year to $38.02 million. The company expects the full year’s revenue to be around $160.5 million, close to analysts’ estimates. Its non-GAAP loss of $0.04 per share was 59.8% above analysts’ consensus estimates.
Via StockStory · June 11, 2025